Intestinal T cells and group 3 innate lymphoid cells (ILC3 cells) control the composition of the microbiota and gut immune responses. Within the gut, ILC3 subsets coexist that either express or lack the natural cytoxicity receptor (NCR) NKp46. We identified here the transcriptional signature associated with the transcription factor T-bet-dependent differentiation of NCR − ILC3 cells into NCR + ILC3 cells. Contrary to the prevailing view, we found by conditional deletion of the key ILC3 genes Stat3, Il22, Tbx21 and Mcl1 that NCR + ILC3 cells were redundant for the control of mouse colonic infection with Citrobacter rodentium in the presence of T cells. However, NCR + ILC3 cells were essential for cecal homeostasis. Our data show that interplay between intestinal ILC3 cells and adaptive lymphocytes results in robust complementary failsafe mechanisms that ensure gut homeostasis.
Dysregulation of intestinal barrier function disrupts gut microbiota and results in inflammation, diarrhea and chronic disease. Mucosal immunity is essential for control of the composition of gut commensal flora and maintenance of health in the face of continual exposure to potentially pathogenic bacteria in the gastrointestinal tract. Interleukin 22 (IL-22) has a crucial role in this immunological control of gut commensal and pathogenic bacteria and is secreted by a heterogeneous population of lymphocytes that express the nuclear hormone receptor and transcription factor RORγt (encoded by Rorc) 1 [2] [3] [4] [5] [6] [7] .
, including subsets of helper T cells (T H 17 and T H 22) and group 3 innate lymphoid cells (ILC3 cells)
ILC3 cells are a heterogeneous population of innate lymphoid cells (ILCs) that are particularly abundant at mucosal sites. They can be divided into three main subsets on the basis of their role during embryogenesis and their cell-surface expression of the natural cytoxicity receptor (NCR) NKp46 (called 'NCR + ' or 'NCR − ' cells here). NCR − ILC3 cells are lymphoid tissue-inducer cells that were originally identified in the fetus and are required for the development of lymph nodes and Peyer's patches 8 . Lymphoid tissue-inducer cells do not require expression of the transcription factor PLZF 9 and can be categorized as CD4 − or CD4 + cells. Another subset of NCR − ILC3 cells requires PLZF and gives rise to NCR + ILC3 cells in a manner dependent on the transcription factor T-bet and the Notch family of receptors 10, 11 . NCR − ILC3 cells can promote colitis in a model of inflammatory bowel disease 12 . In contrast, NCR + ILC3 cells are essential for regulation of the balance between commensal bacteria and pathogenic bacteria through their IL-23-driven production of IL-22, particularly during infection with Citrobacter rodentium 13, 14 . C. rodentium is a Gram-negative mouse-restricted pathogenic bacterium that can be used as a model of the human enteric pathogens enteropathogenic Escherichia coli and enterohemorrhagic E. coli. It colonizes the intestinal mucosa, which leads to the formation of attaching and effacing lesions that result from the effacement of the brush-border microvilli. IL-22 is essential for the control of infection with C. rodentium, as it stimulates the secretion of antimicrobial peptides and protects epithelial function 15 . As a consequence, mice that lack this cytokine rapidly succumb to the disease 16 . NCR + ILC3 cells have a critical role in protection against C. rodentium in mice globally deficient in genes also expressed in B cells or T cells, such as Rag2, Tbx21 or Cxcr6 (refs. 11,13,14,17) . However, these mouse models have profound or partial immunodeficiency, which confounds interpretation of findings obtained with these models, as well as delineation of the Tbx21
selective contributions of NCR − ILC3 cells and NCR + ILC3 cells. Overall, analysis of ILC3 biology has been hampered by the lack of models that selectively target these cells. Here we explored the biology of innate producers of IL-22 in mouse conditional-deletion models that targeted NCR + ILC3 cells but preserved B cells and T cells, to elucidate the specific contributions of NCR + ILC3 cells to intestinal protection. Our comprehensive analysis of gut ILC3 cells reveals a redundant role for NCR + ILC3 cells in the control of C. rodentium infection in immunocompetent hosts and a selective role for NCR + ILC3 cells in cecal homeostasis.
RESULTS

Expression profiles of ILC3 subsets
RORγt + IL-22-producing ILC3 cells have been divided into at least four different subsets, including a T-bet-independent NCR − ILC3 subset comprising CD4 + NKp46 − and CD4 − NKp46 − ILC3 cells, and a T-bet-dependent NCR + ILC3 subset comprising NCR + RORγt int and NCR + RORγt hi ILC3 cells 18, 19 . We investigated the relationships among these four ILC3 populations by isolating CD4 + NCR − ILC3 cells (called 'CD4 + ILC3 cells' here), CD4 − NCR − (called 'doublenegative (DN) ILC3 cells' here), NCR + RORγt int ILC3 cells and NCR + RORγt hi ILC3 cells from the small intestine of reporter mice with heterozygous expression of sequence encoding green fluorescent protein (GFP) knocked into the Rorc locus (Rorc +/GFP mice) ( Fig. 1a ) and performing genome-wide transcriptome analysis by highthroughput sequencing technologies for cDNA (RNA-seq). In these NCR − ILC3 subsets, the transcriptional profiles of the CD4 + NCR − and CD4 − NCR − ILC3 cells were almost identical ( Table 1) , which indicated that they could be considered a single population of NCR − ILC3 cells. Similarly, NCR + RORγt int and NCR + RORγt hi NCR + ILC3 cells had very similar transcriptional programs ( Table 1 ) and differed only in the expression of genes encoding a set of chemokines and chemokine receptors that guide tissue localization, including Ccl5, Ccl4, Cxcr5 and Ccr5 ( Supplementary Table 1 ). Thus, NCR + RORγt int and NCR + RORγt hi cells were also extremely similar and could be considered a single population of NCR + ILC3 cells. In contrast, there were robust differences in the transcriptional profiles of NCR − ILC3 cells and NCR + ILC3 cells. The expression of genes encoding transcription factors, such as Idb2, Gata3 and Rorc, was similar in these subsets, whereas the expression of Tbx21 and Prdm1 was upregulated in NCR + ILC3 cells ( Table 1) . Genes encoding various other transcriptional regulators were also expressed differentially, including Irf8, which was upregulated in NCR + ILC3 cells, and Batf3 and Tox2, which were downregulated in NCR + ILC3 cells ( Table 1) . Thus, these NCR + ILC3 cells and NCR − ILC3 cells were distinct ILC3 subsets with different transcription programs, consistent with a published microarray analysis 20 ; this confirmed the validity our RNA-seq approach.
Effect of T-bet on ILC3 cells
T-bet is key to the differentiation of NCR − ILC3 cells, as NCR + ILC3 cells are absent from mice deficient in the gene encoding T-bet (Tbx21) 10, 11, 21 ; however, the mechanisms by which T-bet affects ILC3 maturation are unclear. We investigated the transcriptional program of ILC3 cells isolated from Rorc +/GFP Tbx21 +/− mice, which lack one copy of Tbx21. Given that Rorc +/GFP Tbx21 +/− mice have a heterogeneous phenotype, we reasoned that the loss of one allele would reveal (b) Ingenuity pathway analysis of genes expressed differentially by NCR − and NCR + ILC3 cells whose expression was different in Tbx21 +/+ NCR + ILC3 cells (Tbx21 +/+ ) than in Tbx21 +/− NCR + ILC3 cells (Tbx21 +/− ) at steady state (that is, expression affected by the loss of a single copy of the gene encoding T-bet), grouping genes by pathways (above plots) in which their products are involved; expression results are presented as log 2 RPKM values ('reads per kilobase of transcript per million reads'; mean and maximum value for each gene). (c) Flow cytometry analyzing NK1.1 and NKG2A/E/C in ILC3 subsets isolated from the intestine of Rorc +/GFP Tbx21 +/+ and Rorc +/GFP Tbx21 +/− mice, gated on live CD45 + Lin − RORγt + cells. Numbers in quadrants indicate percent cells in each, among NCR + ILC3 cells. Data are representative of two independent experiments (n = 2-3 mice per genotype in each). npg differential regulation by T-bet without complete loss of NCR + ILC3 cells, which remained present, albeit at a lower frequency than that in Rorc +/GFP Tbx21 +/+ mice ( Fig. 1a) . We then performed two types of analyses on the RNA-seq transcriptional profile data set obtained with the following eight ILC3 populations: CD4 + NCR − , CD4 − NCR − (DN), NCR + RORγt int and NCR + RORγt hi ILC3 cells from Tbx21 +/+ mice, and the same four subsets from Tbx21 +/− mice. We first compared the list of genes differentially expressed by NCR − ILC3 cells (CD4 + or CD4 − ) and NCR + ILC3 cells (RORγt int or RORγt hi ) in Tbx21 +/+ mice with the same list for Tbx21 +/− mice. In wild-type mice, a total of 674 genes displayed differences in expression by a factor of at least two in NCR − ILC3 cells versus NCR + ILC3 cells; 324 of these genes did not display differential expression between these two cell types in Tbx21 +/− mice (data not shown). Thus, during the transition from NCR − ILC3 to NCR + ILC3, about 50% of genes were affected by the loss of a single copy of Tbx21, which indicated that T-bet guided a substantial component of the NCR + ILC3 developmental program. Second, we compared the gene-expression profiles of ILC3 cells from Tbx21 +/− mice with those from the corresponding Tbx21 +/+ ILC3 populations. We found no role for T-bet in CD4 + or CD4 − NKp46 − ILC3 cells (data not shown). Therefore, as expected, in NCR − ILC3 populations (CD4 + or CD4 − ), very few genes were expressed differentially in Tbx21 +/+ cells relative to their expression in Tbx21 +/− cells. However, we observed substantial differences in the transcriptional profiles of Tbx21 +/+ NCR + ILC3 cells and Tbx21 +/− NCR + ILC3 cells (RORγt int or RORγt hi ): analysis with a cutoff of a difference in expression at least twofold in Tbx21 +/+ NCR + ILC3 cells versus Tbx21 +/− NCR + ILC3 cells showed that 72 genes were upregulated and 86 genes were downregulated in Tbx21 +/+ cells ( Supplementary Table 2 ). This enabled us to investigate the gene programs specifically regulated by T-bet during generation of the NCR + ILC3 subset. Notably, 70% of the genes found to be downregulated in NCR + ILC3 cells in the absence of T-bet had higher expression in NCR + ILC3 cells than in NCR − ILC3 cells ( Fig. 1b) . Loss of a single allele of T-bet affected genes encoding factors that regulate communication between innate cells and adaptive cells, such as cytokines, chemokines and their receptors, including regulation via IL-2Rα (CD25) and interferon signaling through the Jak-Stat pathway, IL-22, CCL4 and CCL5 ( Fig. 1b) . T-bet also regulated various gene clusters encoding products known to be 'preferentially' associated with effector functions such as cytotoxicity and expressed by natural killer (NK) cells (for example, Gzme, Gzma, Ifng and Il12rb) ( Fig. 1b) . These gene clusters also encoded members of the 'killer-cell lectin-like receptor' (KLR) family better known for their inhibitory and activating function in NK cells: Fig. 1b) . Consistent with those genomic analyses, we confirmed the T-bet-dependent regulation of NK1.1 and heterodimers of CD94 and NKG2 in NCR + ILC3 cells at the protein level ( Fig. 1c) . Thus, in addition to being required for the development of NCR + ILC3 cells from NCR − ILC3 cells, T-bet seemed to have a role in the recognition, effector function and migration of NCR + ILC3 cells within tissues. T-bet was also the major driver of the 'NK cell-ness' program of NCR + ILC3 cells.
NCR + ILC3 cells are dispensable in immunocompetent mice
The pathway analysis of ILC3 transcriptomic data revealed that the set of genes expressed in NCR + ILC3 cells and downregulated in Tbx21 +/− mice showed enrichment for in genes encoding products involved in the control of gastrointestinal disease and bacterial infection ( Fig. 1b) . Consistent with those data, NCR + ILC3 cells are reported to be pivotal in protection against C. rodentium in various models of immunodeficient mice 11, 13, 14, 17 . We therefore investigated the role of the IL-22 produced by NCR + ILC3 cells during the course of infection with C. rodentium by specifically deleting IL-22 from NCR + cells; thus, NCR + ILC3 cells were targeted, while NCR − ILC3 cells would remain intact. We used a previously undescribed model of mice with sequence encoding enhanced GFP knocked into both alleles (Il22 eGFP/eGFP ) and expressing 'improved' Cre recombinase (iCre) Fig. 1 ); in these mice, NCR + ILC3 cells were unable to produce IL-22 ( Fig. 2a) . We also crossed Ncr1-iCre mice with mice with loxP-flanked alleles encoding the transcription factor STAT3 (Stat3 fl/fl ), for the selective abolition of STAT3-dependent signaling in NCR + ILC3 cells, as STAT3 is required for the production of IL-22 by ILC3 cells and T H 17 cells, and ablation of Stat3 in RORγt + lymphocytes leads to increased morbidity and mortality after infection with C. rodentium 22 . NCR + ILC3 cells from Il22 eGFP/eGFP Ncr1-iCre and Stat3 fl/fl Ncr1-iCre mice were unable to produce IL-22 ( Fig. 2a) , but both types of mice were resistant to infection with C. rodentium, as we observed no death, weight loss, histological abnormalities in the gut or increase in bacterial dissemination in these mice relative to that of Ncr1-iCre mice ( Figs. 2b and 3) . This resistance could not be accounted for by a compensatory increase in IL-22 production by NCR − ILC3 cells, which were present in normal numbers and produced normal amounts of the cytokine (Supplementary Figs. 1c,d and 2). In contrast, treatment with blocking antibody to IL-22 led to severe colitis and premature death of wild-type mice challenged with the same dose of C. rodentium (Fig. 2b) , as reported before 16 . Thus, IL-22 was essential for resistance to C. rodentium, but the production of IL-22 by NCR + ILC3 cells was dispensable for this. We then ablated NCR + ILC3 cells to address their contribution to the control of infection with C. rodentium more generally. We directly abolished Tbx21 expression in NCR + ILC3 cells by crossing Ncr1-iCre mice with Tbx21 fl/fl mice to generate Tbx21 fl/fl Ncr1-iCre mice. Consistent with findings reported above, the number of NKp46 + RORγt − cells and NCR + ILC3 cells was much smaller in the small intestine and colon of Tbx21 fl/fl Ncr1-iCre mice than in that of Tbx21 fl/fl Ncr1 +/+ mice ( Fig. 4 and Supplementary Fig. 3a) . However, Tbx21 fl/fl Ncr1-iCre mice were resistant to infection with C. rodentium, as we observed no death, weight loss, histological abnormalities in the gut or increase in bacterial dissemination in Tbx21 fl/fl Ncr1-iCre mice relative to that of Tbx21 fl/fl Ncr1 +/+ mice ( Fig. 2b and  Supplementary Fig. 3b-d) . We observed a much greater number of IL-22-producing NCR − ILC3 cells in Tbx21 fl/fl Ncr1-iCre mice than in Tbx21 fl/fl Ncr1 +/+ mice ( Fig. 4 and Supplementary Fig. 3a) , which potentially compensated for the loss of NCR + ILC3 cells in this model. We thus addressed the role of ILC3 cells during infection with C. rodentium further by generating another model of deficiency in NCR + ILC3 cells by crossing Ncr1-iCre mice with mice heterozygous for expression of the gene encoding diphtheria toxin fragment A (DTA) from the ubiquitous Rosa26 locus (R26 DTA/+ ; Rosa-DTA) to generate R26 DTA/ + Ncr1-iCre mice. We observed a nearly complete absence of NKp46 + cells (both NCR + RORγt − cells and NCR + ILC3 cells) in the small npg intestine and colon of R26 DTA/+ Ncr1-iCre mice, with no greater abundance of NCR − ILC3 cells in the small intestine and colon of R26 DTA/ + Ncr1-iCre mice than in that of their Ncr1-iCre littermates ( Fig. 4 and Supplementary Fig. 4a,b) . We recorded no morbidity or mortality for R26 DTA/+ Ncr1-iCre mice infected with C. rodentium (Fig. 2b) . Those findings were supported by a lack of difference between R26 DTA/+ Ncr1-iCre mice and Ncr1-iCre mice in terms of colon length or histology, or bacterial dissemination, as assessed by quantification of colony-forming units (CFU) of C. rodentium in the feces, spleen and liver ( Fig. 5) . We further monitored the immune response to C. rodentium infection in these mice and we found no differences in other parameters, such as the cellularity of the gut lamina propria for CD4 + Fig. 4c-e ). Measurement of cytokines (IFN-γ, IL-17A, Il-1β, IL-6, CXCL1 (KC), TNF and IL-10) in gut extracts revealed no differences between R26 DTA/+ Ncr1-iCre mice and Ncr1-iCre mice (Supplementary Fig. 4f ).
T cells, CD8 + T cells, B cells, Ly6G + Ly6C + myeloid cells and MHCII + CD11c + dendritic cells, or the ability of mesenteric lymph node and splenic CD4 + T cells and CD8 + T cells to produce IL-17A or interferon-γ (IFN-γ) upon ex-vivo stimulation (Supplementary
Mcl-1 is an anti-apoptotic protein induced by signaling via the common γ-chain receptor and is required for the maintenance of NK cells in vivo 23 . We investigated whether Mcl-1 was also required for the maintenance of NCR + ILC3 cells in the gut, through the use of mice with deletion of loxP-flanked Mcl1 alleles by iCre expressed from the Ncr1 locus (Mcl1 fl/fl Ncr1-iCre mice). Both NCR + RORγt − cells and NCR + ILC3 populations were absent from Mcl1 fl/fl Ncr1-iCre mice (Fig. 4) . These data demonstrated a key role for Mcl-1 in the maintenance of all NKp46 + ILCs in vivo. Mcl1 fl/fl Ncr1-iCre mice represent another model of immunodeficiency in which NCR + ILC3 cells are absent but NCR − ILC3 cells and T cells are unaffected. We challenged Mcl1 fl/fl Ncr1-iCre mice with C. rodentium. As noted for R26 DTA/+ Ncr1-iCre mice, Mcl1 fl/fl Ncr1-iCre mice were resistant to the infection (Fig. 2b) , with no sign of disease or bacterial dissemination detected by histology or on the basis of colon length or CFU in the spleen and liver (Supplementary Fig. 5) . Thus, results obtained with five different genetic models converged to reveal that NCR + ILC3 cells were dispensable for the control of C. rodentium infection in immunocompetent mice.
The diminished production of IL-22 by ILC3 cells in mice deficient in the transcription factor AhR allows the proliferation of commensal segmented filamentous bacteria, which are known to promote the development of T H 17 cells 24 . We therefore also investigated the consequences of a lack of NCR + ILC3 cells for gut microbiota at steady state, by deep sequencing. We detected no difference in the presence of particular bacterial families or number of segmented filamentous bacteria in the feces, or in the number of T H 17 cells in the small intestine, in comparisons of R26 DTA/+ Ncr1-iCre mice and Ncr1-iCre mice housed in the same conditions ( Supplementary  Fig. 6a-c) . Similarly, the bacterial families present in the gut of Mcl1 fl/fl Ncr1-iCre mice did not differ from those present in the gut of Ncr1-iCre mice (data not shown). Thus, a deficiency in NCR + ILC3 cells had no effect on the gut microbiota in immunocompetent hosts at steady state.
A role for NCR + ILC3 cells in immunodeficient mice
The results presented above contrasted with published reports of a critical role for NCR + ILC3 cells in protection against C. rodentium in mice deficient in the gene encoding the RAG recombinase component RAG-2 (Rag2), T-bet (Tbx21), the chemokine receptor CXCR6 (Cxcr6) or the transcription factor Id2 (Id2) 11, 13, 14, 17, 25 . As all these mouse models display profound or partial immunodeficiency, we investigated the role of NCR + ILC3 cells in immunodeficient and immunocompetent mice directly, by crossing R26 DTA/+ Ncr1-iCre mice with Rag2 −/− mice, which lack T cells and B cells. We then infected Rag2 −/− Ncr1-iCre mice and Rag2 −/− R26 DTA/+ Ncr1-iCre and R26 DTA/+ Ncr1-iCre littermates with C. rodentium and evaluated their resistance to bacterial infection by monitoring mouse weight and survival. Consistent with our findings reported above, R26 DTA/+ Ncr1-iCre mice were resistant to C. rodentium (Fig. 6) . After initial npg A r t i c l e s control of the infection, Rag2 −/− Ncr1-iCre mice lost weight and started to succumb to the disease on day 17 after infection ( Fig. 6) , as reported before 26 . Rag2 −/− R26 DTA/+ Ncr1-iCre mice were even more susceptible to the infection than were their Rag2 −/− Ncr1-iCre littermates, as shown by their greater weight loss on days 12-14 after infection, with the first mice dying on day 13 and all mice dead by day 22, in contrast to the death of all Rag2 −/− Ncr1-iCre mice by day 26 (Fig. 6) . Thus, NCR + ILC3 cells were not essential for the control of C. rodentium in immunocompetent hosts, whereas they contributed to the control of C. rodentium in immunodeficient mice.
A role for NCR + ILC3 cells in cecal homeostasis
In contrast to the lack of effect of deficiency in NCR + ILC3 cells in the small intestine or the bulk of the colon, the absence of NCR + ILC3 cells in Mcl1 fl/fl Ncr1-iCre mice during infection with C. rodentium resulted in a smaller cecum than that of wild-type mice, together with ulceration and bleeding (Fig. 7a) . We also observed those pathological features in the cecum of Stat3 fl/fl Ncr1-iCre mice infected with C. rodentium (Fig. 7b) . Those features were accompanied by crypt hyperplasia and inflammation, as shown by the staining of cecal sections with hematoxylin and eosin (Fig. 7c) . We observed no alteration in the cecum, small intestine or colon at steady state in any of the five genetic models of deficiency in NCR + ILC3 cells (Mcl1 fl/fl Ncr1-iCre,
Stat3 fl/fl Ncr1-iCre) (data not shown). Thus, NCR + ILC3 cells had a role in protecting the cecum during C. rodentium infection, and this function was abolished in conditions in which NCR + ILC3 cells were unable to produce IL-22. We further delineated the role of NKp46 + cells in the control of cecal homeostasis during infection with C. rodentium by assessing the regional distribution of gut ILCs. C. rodentium is a colonic infection, but it begins in the cecum. In wild-type mice, the protective role of NKp46 + cells was associated with a high frequency of NCR + ILC3 cells in the cecum at steady state, in contrast to the low frequency of NCR + ILC3 cells in the colon (Fig. 7d) . At the junction of the small intestine and the colon, the cecum was globally characterized by a distribution of ILCs with features of both the small intestine, with a high frequency of NCR + ILC3 cells, and the colon, with a low frequency of NCR − ILC3 cells (Fig. 7d) . In wild-type mice, this distribution of intestinal ILCs underwent profound alteration over the course of C. rodentium infection, as the frequency of NCR + ILC3 cells was considerably lower in the cecum and colon (Fig. 7e) . The causes and consequences of these changes remain to be fully explored. A characteristic feature of cecal NCR + ILC3 cells is their high density of cell-surface expression of NK1.1, in contrast to the low density of NK1.1 at the surface of NCR + ILC3 cells in the small intestine and its intermediate expression on NCR + ILC3 cells in the colon (Supplementary Fig. 7a ). The role of NK1.1 is unknown, npg but these data provide an explanation for the reported deleterious effect of treatment with antibody to NK1.1 on Rag2 −/− mice infected with C. rodentium 14 . Indeed, treatment with depleting antibody to NK1.1 decreased the number of NCR + ILC3 cells, particularly in the cecum, but also in the colon to some extent, whereas it had no effect on the number of NCR + ILC3 cells in the small intestine ( Supplementary Fig. 7b ). Treatment with antibody to NK1.1 also resulted in depletion of NKp46 + RORγt − cells, including NK cells, ILC1 cells and 'ex-ILC3' (formerly ILC3) cells (Supplementary Fig. 7b ). However, all NKp46 + RORγt − cells produce IFN-γ, and IFN-γ-deficient mice are not more sensitive to C. rodentium infection 26 , in contrast to IL-22-deficient mice 16 . Overall, these results suggested that cecal NK1.1 + NCR + ILC3 cells were involved in the control of infection with C. rodentium, through their production of IL-22.
DISCUSSION
The aim of this study was to delineate the biology of NCR + ILC3 cells, a subset of IL-22-producing ILCs of the gut, and their interplay with adaptive immunity in the context of a colonic infection, in the C. rodentium model. By using Ncr1-iCre mice, in which NCR + cells are selectively targeted, we were able to highlight the intrinsic roles of the molecules encoded by Tbx21, Mcl1 and Stat3 in the development, maintenance and function of NCR + ILC3 cells. The generation of Il22 eGFP/eGFP Ncr1-iCre mice also made it possible to carry out functional fate mapping of IL-22-producing NCR + ILC3 cells, without detectable cofounding effects due to under-reporting of the Il22-Cre transgene 27 . Using these mice, we detected no IL-22 production by intestinal RORγt − NKp46 + cells, including NK cells, ILC1 cells and 'ex-ILC3' cells 28 . Our findings contrast with those of other studies reporting the production of IL-22 by human and mouse NK cells from various inflamed tissues [29] [30] [31] [32] [33] and lead us to reconsider whether RORγt − ILCs might produce IL-22. We also showed that neither the production of IL-22 by NCR + ILC3 cells nor the cells themselves were essential for the control of intestinal infection by C. rodentium in immunocompetent hosts. In these mice, NCR + ILC3 cells did not control the gut commensal microbiota either. Published studies have shown that NCR + ILC3 cells have a critical role in protection against C. rodentium in mice with profound or partial immunodeficiency 11, 13, 14, 17 . Our results are consistent with published reports 10, 34 and challenge the current dogma in revealing that NCR + ILC3 cells were not essential for the control of intestinal infection in the presence of T cells. We also found that NCR + ILC3 cells were able to confer some protection against C. rodentium when T cells were absent. The critical role of IL-22producing T cells in the control of C. rodentium infection has already been demonstrated 26 . Published studies have investigated the contributions of T H 17 cells and T H 22 cells during the late phases of C. rodentium infection 26 and have suggested that the IL-22 produced by the total ILC3 population (consisting of multiple subsets) is important early in C. rodentium infection, but that once T cells are activated, ILC3 cells seem to be dispensable 13, 16, 22, 26, 27, 35 . Thus, NCR + ILC3 cells, NCR − ILC3 cells and T H 17 or T H 22 cells can display some functional redundancy. It has also been suggested that NCR − ILC3 cells provide an adequate barrier to C. rodentium infection 36 , as they produce large amounts of IL-22 in the gut 27 . However, we found here that these cells were not sufficient to confer protection against C. rodentium in T cell-compromised mice in the presence or absence of NCR + ILC3 cells. Nevertheless, formal elucidation of the role of NCR − ILC3 cells in the control of the gut commensal and pathogenic microbiota awaits the development of tools for the selective ablation of this cell population.
The interplay between T cells and ILCs is a matter of great interest. ILCs can interact with CD4 + T cells via major histocompatibility complex class II molecules, which limits the pathological responses of cells of the adaptive immune system to commensal bacteria 37 . It has also been suggested that T cells function as antigen-specific sensors for the activation of ILCs, to amplify and 'instruct' local immune responses 38 . We have described here another type of relationship between T cells and ILC3 cells in which NCR + ILC3 cells partly overcame the lack of T cells for protection against the pathogenic bacterium C. rodentium but became redundant when T cells were present. This is, to our knowledge, the first formal demonstration of redundancy between T cells and ILCs. T cells and ILCs have evolved similar effector functions despite their use of different recognition strategies: a germline-encoded receptor for ILCs, and antigen receptors generated by site-specific somatic recombination for T cells. We thus speculate that ILC3 cells and T H 17 or T H 22 cells have evolved together, which has led to the selection of robust failsafe mechanisms for ensuring adequate control of commensal gut microbiota and protection against intestinal infections. Selective pressure for redundancy might have led to the similarities between ILCs and T cells in terms of their distribution and effector function.
Unexpectedly, we observed severe pathological features in the cecum after the ablation of NCR + ILC3 cells. Similar severe cecal lesions have also been observed in IL-22-deficient mice after infection with C. rodentium 16 , in support of the possibility of a role for NCR + ILC3 cells, the only NKp46 + cells that can produce IL-22, in the altered cecal phenotype. The cecum is the first site in the gastrointestinal tract to be colonized by C. rodentium during infection, with invasion of the colon occurring later (at approximately day 8) (ref. 39) .
We thus propose a model in which NCR + ILC3 cells are redundant with T cells for protection against lethality and colon disease during intestinal infection but are critical for protection against cecal damage at the earliest stage of infection. The cecum is a blind pouch at the junction between the small intestine and the large intestine. It is a source of bacteria and is also linked to the appendix in humans and mice, in which it is referred to as the 'cecal patch' . The appendix has generally been seen as a vestige of evolution, but phylogenetic studies have challenged the apparent lack of function of the cecum and appendix 40 . In particular, it has been suggested that the cecum and appendix provide an important reservoir for maintenance of the gut flora, which is anatomically protected from the intestinal lumen and might allow seeding of the gut after dysbiosis. Our data demonstrating a critical role for NCR + ILC3 cells in the homeostasis of the cecum upon bacterial infection opens up new possibilities for delineating the role of ILC3 cells in the pathophysiology of the cecum and appendix and in maintaining the health of the intestinal tract.
In particular, future studies should determine whether the balance between NCR − ILC3 cells and NCR + ILC3 cells is involved in the still-unknown mechanisms that lead to appendicitis and resistance or susceptibility to inflammatory bowel diseases, as these two conditions might be related 41 .
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